# Effect of Naloxegol on Gastric, Small Bowel, and Colonic Transit in Healthy Subjects

> **NCT02737059** · PHASE1 · COMPLETED · sponsor: **Michael Camilleri** · enrollment: 72 (actual)

## Conditions studied

- Constipation Drug Induced

## Interventions

- **DRUG:** Naloxegol
- **DRUG:** Codeine
- **DRUG:** codeine placebo
- **DRUG:** naloxegol placebo

## Key facts

- **NCT ID:** NCT02737059
- **Lead sponsor:** Michael Camilleri
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-01
- **Primary completion:** 2017-05-10
- **Final completion:** 2017-05-10
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2017-08-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02737059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02737059, "Effect of Naloxegol on Gastric, Small Bowel, and Colonic Transit in Healthy Subjects". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02737059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*